Tilray Brands (NASDAQ:TLRY) Stock Price Down 3.7% – What’s Next?

Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report)’s share price was down 3.7% during mid-day trading on Monday. The stock traded as low as $2.33 and last traded at $2.34. 4,202,940 shares changed hands during trading, a decline of 2% from the average session volume of 4,281,334 shares. The stock had previously closed at $2.43.

Analyst Upgrades and Downgrades

TLRY has been the topic of several research reports. Canaccord Genuity Group dropped their price objective on Tilray Brands from $4.50 to $4.00 and set a “hold” rating on the stock in a report on Friday, October 9th. TD lowered their price objective on shares of Tilray Brands from $4.70 to $4.50 and set a “buy” rating on the stock in a research note on Monday, October 5th. ATB Cormark Capital Markets cut their target price on Tilray Brands from $8.00 to $6.00 and set a “hold” rating on the stock in a report on Monday, September 21st. Wall Street Zen cut Tilray Brands from a “hold” rating to a “sell” rating in a report on Saturday, August 1st. Finally, TD Securities upgraded Tilray Brands to a “strong-buy” rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Tilray Brands currently has an average rating of “Hold” and an average target price of $5.90.

Read Our Latest Report on Tilray Brands

Tilray Brands Stock Down 3.7%

The stock has a fifty day moving average of $3.40 and a two-hundred day moving average of $5.19. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.88 and a quick ratio of 1.11. The firm has a market capitalization of $345.83 million, a price-to-earnings ratio of -1.67 and a beta of 2.04.

Tilray Brands (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Thursday, October 8th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.16. The business had revenue of $257.15 million for the quarter, compared to analysts’ expectations of $266.26 million. Tilray Brands had a negative return on equity of 10.39% and a negative net margin of 16.91%. Sell-side analysts anticipate that Tilray Brands, Inc. will post -0.52 earnings per share for the current year.

Hedge Funds Weigh In On Tilray Brands

Large investors have recently modified their holdings of the company. Cetera Investment Advisers boosted its position in shares of Tilray Brands by 37.5% during the third quarter. Cetera Investment Advisers now owns 129,123 shares of the company’s stock valued at $484,000 after purchasing an additional 35,228 shares in the last quarter. FORA Capital LLC purchased a new position in shares of Tilray Brands in the third quarter valued at $55,000. Ieq Capital LLC lifted its holdings in shares of Tilray Brands by 88.2% in the 3rd quarter. Ieq Capital LLC now owns 60,999 shares of the company’s stock valued at $229,000 after acquiring an additional 28,590 shares during the last quarter. R Squared Ltd raised its position in Tilray Brands by 35.5% during the third quarter. R Squared Ltd now owns 37,754 shares of the company’s stock valued at $142,000 after purchasing an additional 9,893 shares during the period. Finally, State of Wyoming grew its position in shares of Tilray Brands by 114.2% in the 3rd quarter. State of Wyoming now owns 81,502 shares of the company’s stock worth $306,000 after buying an additional 43,448 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Tilray Brands

(Get Free Report)

Tilray Brands is a global cannabis and consumer packaged goods company. Its cannabis business produces and sells medical and adult-use products, including dried flower, oils, extracts and edibles, under brands such as Good Supply, Solei, Redecan and Broken Coast. The company serves customers in Canada, the United States and international markets. Its activities include medical cannabis distribution in countries where permitted, as well as cannabis and hemp-related products in North America, subject to local regulations.

Recommended Stories

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.